Holen Sie sich die Stockscreener-App
8.68
1.25%
-0.11
Handel nachbörslich:
8.55
-0.13
-1.50%
Schlusskurs vom Vortag:
$8.79
Offen:
$8.84
24-Stunden-Volumen:
627.02K
Relative Volume:
0.69
Marktkapitalisierung:
$355.15M
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-10.59
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
+0.23%
1M Leistung:
-1.36%
6M Leistung:
-45.24%
1J Leistung:
-83.01%
1-Tages-Spanne:
$8.49
$8.98
1-Wochen-Bereich:
$8.32
$8.98
52-Wochen-Spanne:
$6.32
$55.57
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
8.68 | 359.65M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Herabstufung | Jefferies | Buy → Hold |
| 2025-07-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
Rxsight Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
Will RxSight Inc. stock benefit from commodity pricesWeekly Market Summary & Free Expert Verified Stock Movement Alerts - newser.com
Best data tools to analyze RxSight Inc. stockMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - newser.com
Is RxSight Inc. showing signs of accumulationQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - newser.com
Why RxSight Inc. stock is favored by top institutionsJuly 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com
Applying Elliott Wave Theory to RxSight Inc.Market Risk Analysis & Daily Profit Focused Screening - newser.com
Can RxSight Inc. stock continue upward trendMarket Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Does RxSight Inc. qualify in momentum factor screening2025 Analyst Calls & Daily Profit Maximizing Trade Tips - newser.com
Y Intercept Hong Kong Ltd Invests $1.43 Million in RxSight, Inc. $RXST - MarketBeat
Will a bounce in RxSight Inc. offer an exit2025 Sector Review & Stock Portfolio Risk Control - newser.com
Is RxSight Inc. stock a top momentum playJuly 2025 Trade Ideas & Daily Market Momentum Tracking - newser.com
Combining price and volume data for RxSight Inc.Weekly Stock Summary & Entry Point Confirmation Signals - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Investors to Inquire about Securities Investigation - ACCESS Newswire
Real time breakdown of RxSight Inc. stock performanceTreasury Yields & Fast Gaining Stock Reports - newser.com
Analyzing drawdowns of RxSight Inc. with statistical toolsWatch List & Community Verified Swing Trade Signals - newser.com
Building trade automation scripts for RxSight Inc.Watch List & Consistent Growth Equity Picks - newser.com
Can you recover from losses in RxSight Inc.Portfolio Risk Report & High Return Trade Opportunity Guides - newser.com
RxSight (RXST) Expected to Announce Earnings on Thursday - MarketBeat
Is RxSight Inc. meeting your algorithmic filter criteriaGap Up & Safe Swing Trade Setups - newser.com
Tools to monitor RxSight Inc. recovery probabilityWeekly Trade Analysis & Low Drawdown Momentum Ideas - newser.com
Why RxSight Inc. stock remains undervaluedTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Investors to Reach Out - ACCESS Newswire
Can RxSight Inc. stock resist sector downturnsJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out - ACCESS Newswire
How analysts rate RxSight Inc. stock todayMarket Activity Recap & Stepwise Entry/Exit Trade Alerts - fcp.pa.gov.br
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):